I

InnaVirVax

50 employees

InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
infectious diseases
Therapeutics
HIV disease prognostic
cancer
HIV therapy

Date founded

2008

Funding rounds raised

Total raised

$1.6M

from 1 investors over 1 rounds

I

InnaVirVax raised $1.6M on June 1, 2009

Investors: Karista

FAQ